Results 101 to 110 of about 1,128,805 (202)

Prophylactic IFN-γ blockade drives axi-cel expansion without preventing refractory toxicities: caution against pre-emptive use. [PDF]

open access: yesBlood Cancer Discov
Blumenberg V   +18 more
europepmc   +1 more source

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]

open access: yesJ Clin Oncol
Neelapu SS   +22 more
europepmc   +1 more source

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. [PDF]

open access: yesJ Clin Oncol, 2021
Frank MJ   +17 more
europepmc   +1 more source

State capture and development: a conceptual framework. [PDF]

open access: yesJ Int Relat Dev (Ljubl), 2023
Dávid-Barrett E.
europepmc   +1 more source

Youth-Friendly Sexual Health Services and Peer Support for Improved Sexual and Reproductive Health Outcomes Among Adolescents and Young Adults in South Africa: Results of a Factorial Randomized Controlled Trial. [PDF]

open access: yesSex Transm Dis
Jarolimova J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy